Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations
Public ClinicalTrials.gov record NCT03812172. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Screening for Cardiac Amyloidosis With Nuclear Cardiology for Minority Populations
Study identification
- NCT ID
- NCT03812172
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Mathew S. Maurer, MD
- Other
- Enrollment
- 646 participants
Conditions and interventions
Interventions
- 99mTc-PYP or 99m Tc-HDP Drug
Drug
Eligibility (public fields only)
- Age range
- 60 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 14, 2019
- Primary completion
- Jun 11, 2024
- Completion
- Dec 12, 2024
- Last update posted
- Nov 18, 2025
2019 – 2024
United States locations
- U.S. sites
- 4
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Yale University/Yale New Haven Medical Center | New Haven | Connecticut | 06519 | — |
| Boston Medical Center/Boston University Medical Center | Boston | Massachusetts | 02118 | — |
| Columbia University Irving Medical Center | New York | New York | 10032 | — |
| Harlem Hospital | New York | New York | 10037 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03812172, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 18, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03812172 live on ClinicalTrials.gov.